COMPASS Pathways (CMPS) Expected to Announce Earnings on Thursday

COMPASS Pathways (NASDAQ:CMPS) will likely be releasing its earnings data before the market opens on Thursday, February 27th. Analysts expect COMPASS Pathways to post earnings of ($0.62) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

COMPASS Pathways Price Performance

CMPS stock opened at $3.65 on Wednesday. The firm has a market cap of $249.74 million, a price-to-earnings ratio of -1.66 and a beta of 2.28. The company has a quick ratio of 8.91, a current ratio of 8.91 and a debt-to-equity ratio of 0.15. COMPASS Pathways has a 12-month low of $3.16 and a 12-month high of $12.75. The company’s fifty day simple moving average is $4.07 and its 200 day simple moving average is $5.30.

Analyst Upgrades and Downgrades

CMPS has been the topic of several research reports. Maxim Group dropped their price objective on shares of COMPASS Pathways from $22.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, November 1st. HC Wainwright dropped their price objective on shares of COMPASS Pathways from $60.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $18.00 price objective on shares of COMPASS Pathways in a report on Wednesday, January 15th. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, COMPASS Pathways currently has a consensus rating of “Buy” and an average price target of $30.60.

COMPASS Pathways Company Profile

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.